Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats
4 affiliations
- 1Department of Veterinary Clinical Sciences, The Ohio State University College of Veterinary Medicine, Columbus, Ohio 43210, United States
- 2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota 55905, United States
- 3Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, United States
- 4Department of Biomedical Informatics, The Ohio State University Medical Center, Columbus, Ohio 43210, United States
Abstract
Chronic kidney disease (CKD) is one of the most prevalent diseases in feline medicine. Mass spectrometry-based urinary proteomics offers powerful insight into biomarker candidates and disease subtyping in CKD by measuring protein profiles rather than individual proteins. This study aims to measure the urinary proteome to identify protein profiles in cats with and without CKD to gain pathophysiological insights into the disease and more precisely diagnose CKD. Here, we identify 2,219 urinary proteins in the feline urinary proteome. Using univariate biomarker analysis, we show that MMP-7 may be a promising biomarker of CKD in cats. We then demonstrate the power of using protein profiles rather than individual proteins by grouping proteins based on how they trend across disease states. The changes to the global urinary proteomes of individual cats showed three distinct groups of CKD cats with unique protein profiles, suggesting that different pathophysiological mechanisms mediate disease subtypes. We demonstrate that large-scale urinary proteomics may provide a powerful framework for discovering candidate biomarkers that advance the subtyping and mechanistic understanding of feline CKD.
Related
- Leveraging high-throughput proteomics and AI-based protein folding to accelerate VAV1 molecular glue discovery.
- Structural diversity of human urinary N-glycans revealed by reversed-phase LC/MS/MS toward a resource for biomarker discovery
- Proteomics to advance meat research: Mapping and integrating biomarker-pathway interactions underlying beef marbling, color, and tenderness in longissimus muscle
- Model-Dependent EV Biomarker Signatures: From Culture Systems to Translational Perspectives
- Non-invasive glycemic control leveraging ultrasound dose window activation of MscL in diabetic mice
BibTeX
@article{brusach2026leveraging,
title = {{Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats}},
author = {Katelyn B. Brusach and Ariana E. Shannon and Brian C. Searle and Jessica M. Quimby},
journal = {Journal of Proteome Research},
year = {2026},
month = oct,
doi = {10.1021/acs.jproteome.6c00357},
url = {https://doi.org/10.1021/acs.jproteome.6c00357},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Leveraging Urinary Proteomics to Advance Pathophysiologic and Biomarker Perspectives of Chronic Kidney Disease in Cats
AU - Katelyn B. Brusach
AU - Ariana E. Shannon
AU - Brian C. Searle
AU - Jessica M. Quimby
PY - 2026
DA - 2026/10/14
JO - Journal of Proteome Research
DO - 10.1021/acs.jproteome.6c00357
UR - https://doi.org/10.1021/acs.jproteome.6c00357
AB - Chronic kidney disease (CKD) is one of the most prevalent diseases in feline medicine. Mass spectrometry-based urinary proteomics offers powerful insight into biomarker candidates and disease subtyping in CKD by measuring protein profiles rather than individual proteins. This study aims to measure the urinary proteome to identify protein profiles in cats with and without CKD to gain pathophysiological insights into the disease and more precisely diagnose CKD. Here, we identify 2,219 urinary proteins in the feline urinary proteome. Using univariate biomarker analysis, we show that MMP-7 may be a promising biomarker of CKD in cats. We then demonstrate the power of using protein profiles rather than individual proteins by grouping proteins based on how they trend across disease states. The changes to the global urinary proteomes of individual cats showed three distinct groups of CKD cats with unique protein profiles, suggesting that different pathophysiological mechanisms mediate disease subtypes. We demonstrate that large-scale urinary proteomics may provide a powerful framework for discovering candidate biomarkers that advance the subtyping and mechanistic understanding of feline CKD.
SN - 1535-3893
SN - 1535-3907
ER -